TG Therapeutics filed reports with the Securities and Exchange Commission on June 28, 2026.
4 reports, 3 independent
Updated Aug 27
Gone quiet
- Reports
- 4
- Developments
- 4
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TG Therapeutics filed reports with the Securities and Exchange Commission on June 28, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.PDT Partners bought stock in TG Therapeutics, triggering SEC filings.1 source
TG Therapeutics filed new disclosures with the SEC on July 25, 2026.1 source
TG Therapeutics filed another required investment activity report with the SEC.1 source
TG Therapeutics filed reports with the SEC.1 source
Keep exploring
The entities involved
-
TG Therapeutics
a commercial stage biopharmaceutical company
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- SentinelOne filed reports with the Securities and Exchange Commission on September 10, 2026.
- Encompass Health filed disclosures with the Securities and Exchange Commission on September 19, 2026.
- Element Solutions filed reports with the Securities and Exchange Commission on August 22, 2025.
- Range Resources Corporation filed disclosures with the Securities and Exchange Commission on August 31, 2026.
- TechnipFMC plc filed required reports with the Securities and Exchange Commission on August 17, 2026.
Coverage
Newest first; wire copies grouped- dailypolitical.com
- dailypolitical.comTG Therapeutics, Inc. $TGTX Shares Purchased by Gibbs Wealth Management
- tickerreport.com
- themarketsdaily.com